ADVERTISEMENT

ADVERTISEMENT

Narayana Veeraraghavan joins L7 Informatics as science and AI VP

He will lead the company's scientific AI strategy and help expand the adoption of its enterprise AI platform across customers.

 Narayana Veeraraghavan Narayana Veeraraghavan / L7 Informatics

Austin-based life sciences software company, L7 Informatics has appointed Indian-origin artificial intelligence and bioinformatics expert Narayana (Ray) Veeraraghavan as vice president of science and AI. 

In his new role, Veeraraghavan will report to chief executive officer Vasu Rangadass and lead the company's scientific content strategy, oversee the adoption of its L7|SYNAPSE agentic AI platform across customers, and advise key enterprise clients.

Veeraraghavan brings more than 24 years of experience in artificial intelligence, machine learning, bioinformatics and regulated life sciences. Before joining L7, he served as executive director of bioinformatics and data science innovation at Quest Diagnostics, where he led AI initiatives for the company's molecular diagnostics business and participated in selecting L7's enterprise science platform for clinical operations.

Also read: Hexaware appoints Srinivasan Panchapakesan chief platform officer

Earlier in his career, Veeraraghavan worked at Rady Children's Institute for Genomic Medicine, where he helped develop what the company described as the world's first AI-enabled rapid whole-genome sequencing clinical workflow. The system received a Guinness World Record, Bio-IT World Best Practices recognition and was featured in the journal Nature.

Veeraraghavan will now focus on developing standardized scientific workflows and reusable AI content to help life sciences organizations deploy artificial intelligence within regulated research and manufacturing environments.

"He knows our platform not as an outsider but as someone who evaluated and chose it for critical work. Our vision is to unify a customer's entire physical operation into a single, living architecture, and Ray understands what that takes because he has lived it. Bringing that perspective onto our executive team reflects the partnership we want with the life sciences community,” CEO Rangadass said in a statement. 

Veeraraghavan said he joined the company to help bridge the gap between AI models and real-world scientific applications.

"I have spent more than two decades digitizing workflows and embedding AI inside regulated science to accelerate operational efficiencies, and I have seen how often good work stalls in the gap between a promising model and a deployable workflow," said Veeraraghavan.  

Veeraraghavan holds a PhD from and MS from Pennsylvania State University and a BE from the University of Mumbai.

Discover more at New India Abroad.

Comments

Leave A Comment

Required fields are marked (*).

Related

Talk to us?